Lucid Diagnostics Announces Closing of Public Offering of Common Stock
Press Releases
Lucid Diagnostics  
April 11, 2025

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

NEW YORK, April 11, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM),

avatar profile Olean Times Herald

Olean Times Herald


Local & Social